Vivos Primarna funkcija: Sistem za oftalmološko kirurgijo – avtor Olcayto Guelec and David Geuder

Delo Vivos Primarna funkcija: Sistem za oftalmološko kirurgijo avtorja Olcayto Guelec and David Geuder je izjemno cenjeni dobitnik prestižne nagrade 2026 Zlata nagrada A' Design Award v tekmovalni kategoriji Oblikovanje medicinskih naprav in medicinske opreme.

ZlataMedicinski izdelek· 2026

Vivos Primarna funkcija: Sistem za oftalmološko kirurgijo

avtor/ica: Olcayto Guelec and David Geuder

Naročnik: Geuder AG

Dobitnik nagrade Zlata nagrada A' Design Award v kategoriji Medicinski izdelek

56,783

Potrjeni dobitnik nagrade

Preverite status nagrade za #182492

Ogled na A' Design Award Sporočilo za javnost Značka nagrade

Barve

Dizajn

O dizajnu Vivos Primarna funkcija: Sistem za oftalmološko kirurgijo

Vivos na novo opredeljuje kirurško delovno postajo kot platformo, ki se razvija skladno s kliničnimi ambicijami. Tri konfiguracije, Core, Nova in Nova+, razširjajo zmogljivosti brez zamenjave sistema, kar je edinstvena arhitektura nadgradnje te vrste v oftalmološki kirurgiji. Enoten vmesnik, potrjen s 91,7-odstotnim zadovoljstvom ob prvi uporabi brez predhodnega usposabljanja, odraža zasnovo, zgrajeno okoli kirurga in ne postopka. Osvetljeni priključki za instrumente, prefinjeni materiali in zadržana obdelava dajejo napravi mirno in samozavestno prisotnost, brez vizualnega šuma, značilnega za to kategorijo.

Priznanje

O nagradi Zlata nagrada A' Design Award

Vivos Primarna funkcija: Sistem za oftalmološko kirurgijo je prejemnik Zlate nagrade A' Design Award, neizmerno prestižnega priznanja, ki se podeljuje prvovrstnim, čudovitim in izvrstnim oblikovanjem. Prejemniki Zlate nagrade so izjemno inovativne, vizionarske in bleščeče osupljive stvaritve, ki odražajo genij, modrost in mojstrstvo svojih oblikovalcev. Od Vivos Primarna funkcija: Sistem za oftalmološko kirurgijo se pričakuje, da bo zelo hvaljen, trende postavljajoč in monumentalen izum, ki prinaša brezprecedenčno vrednost. To oblikovanje, nagrajeno z Zlato nagrado A' Design Award, je spektakularno, spoštovano delo, ki v veliki meri koristi in premika meje umetnosti, znanosti, oblikovanja in tehnologije. Vivos Primarna funkcija: Sistem za oftalmološko kirurgijo ustvarja intenzivna čustva želje, prebuja strast, spodbuja ustvarjalnost in nas prevzame.

V ozadju dizajna

Komplet za medije

Zasluge, člani ekipe in tehnične podrobnosti, ki jih je posredoval oblikovalec.

Edinstvene lastnosti: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimenzije in embalaža: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Oznake: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Proizvodna tehnologija: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Oblikovalski izziv: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Raziskave: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiracija: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Trajanje projekta: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Potek delovanja: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Člani ekipe: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Zasluge za slike: Photography Geuder AG, 2026